Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$3.27 - $8.76 $413,988 - $1.11 Million
-126,602 Closed
0 $0
Q1 2022

May 06, 2022

BUY
$7.56 - $14.3 $957,111 - $1.81 Million
126,602 New
126,602 $1.04 Million
Q1 2021

May 05, 2021

SELL
$20.71 - $51.02 $249,286 - $614,127
-12,037 Closed
0 $0
Q4 2020

Feb 04, 2021

SELL
$21.84 - $44.0 $806,463 - $1.62 Million
-36,926 Reduced 75.42%
12,037 $441,000
Q3 2020

Nov 02, 2020

SELL
$13.63 - $24.12 $108,031 - $191,175
-7,926 Reduced 13.93%
48,963 $1.06 Million
Q2 2020

Aug 05, 2020

BUY
$7.65 - $14.11 $207,031 - $381,858
27,063 Added 90.74%
56,889 $737,000
Q1 2020

May 04, 2020

BUY
$4.75 - $12.41 $141,673 - $370,140
29,826 New
29,826 $241,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $265M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.